Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2026-02-08 @ 8:59 AM
Study NCT ID:
NCT05103904
Status:
RECRUITING
Last Update Posted:
2024-12-27
First Post:
2021-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
Sponsor:
Emory University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Recurrent Hepatocellular Carcinoma | View |
| None | Stage III Hepatocellular Carcinoma AJCC V8 | View |
| None | Stage IIIA Hepatocellular Carcinoma AJCC V8 | View |
| None | Stage IIIB Hepatocellular Carcinoma AJCC V8 | View |
| None | Stage IV Hepatocellular Carcinoma AJCC V8 | View |
| None | Stage IVA Hepatocellular Carcinoma AJCC V8 | View |
| None | Stage IVB Hepatocellular Carcinoma AJCC V8 | View |
| None | Unresectable Hepatocellular Carcinoma | View |
Keywords: